Cargando…

Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy

INTRODUCTION: Helicobacter pylori (Hp)-related dyspepsia has been related to gastroduodenal dysbiosis. The role of probiotic supplementation in the clinical management of Hp infection has been the object of several studies in terms of improvement of efficacy and tolerability of eradication treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinelli, Paride, Scalese, Giulia, Covelli, Antonio, Ruffa, Andrea, Bedetti, Giorgio, Bruno, Giovanni, Severi, Carola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760799/ https://www.ncbi.nlm.nih.gov/pubmed/36545196 http://dx.doi.org/10.3389/fmicb.2022.932331

Ejemplares similares

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Comparison of Azithromycin and Metronidazole in a Quadruple-Therapy Regimen for Helicobacter pylori Eradication in Dyspepsia
por: Agah, Shahram, et al.
Publicado: (2009)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation
por: Noorbakhsh, Nafeh, et al.
Publicado: (2022)

Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
por: Yoon, Jai Hoon, et al.
Publicado: (2012)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and Helicobacter pylori Eradication Therapy
por: Sun, Yingchao, et al.
Publicado: (2022)

Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia
por: Muresan, Iulia Antonia Pop, et al.
Publicado: (2019)

Lactobacillus rhamnosus GG as an Effective Probiotic for Murine Giardiasis
por: Goyal, Nisha, et al.
Publicado: (2011)

Stability of Lactobacillus rhamnosus GG in prebiotic edible films
por: Soukoulis, Christos, et al.
Publicado: (2014)

Impact of spray‐drying on the pili of Lactobacillus rhamnosus GG
por: Kiekens, Shari, et al.
Publicado: (2019)

Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response
por: Owens, Joshua A., et al.
Publicado: (2021)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides
por: Allonsius, Camille N., et al.
Publicado: (2017)

Combined effect of arginine and fluoride on the growth of Lactobacillus rhamnosus GG
por: Bijle, Mohammed Nadeem, et al.
Publicado: (2021)

Lactobacillus rhamnosus GG modifies the metabolome of pathobionts in gnotobiotic mice
por: Kim, Jinhee, et al.
Publicado: (2021)

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2022)

The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after Helicobacter pylori Eradication: A Randomized Controlled Trial
por: Wu, Dingkun, et al.
Publicado: (2022)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
por: Kazemi Veysari, Arash, et al.
Publicado: (2023)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

Susceptibility-guided bismuth quadruple therapies for resistant Helicobacter pylori infections
por: Yang, Tiankuo, et al.
Publicado: (2020)

No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients
por: Rubin, Ingrid Maria Cecilia, et al.
Publicado: (2022)

Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children
por: Hong, Jeana, et al.
Publicado: (2012)

Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates
por: Shin, Kiwon, et al.
Publicado: (2021)

Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
por: Hajiani, Eskandar, et al.
Publicado: (2022)

Influence of fermentation conditions on the surface properties and adhesion of Lactobacillus rhamnosus GG
por: Deepika, Gurjot, et al.
Publicado: (2012)

Towards a better understanding of Lactobacillus rhamnosus GG - host interactions
por: Segers, Marijke E, et al.
Publicado: (2014)

Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG
por: Allonsius, Camille Nina, et al.
Publicado: (2019)

Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
por: Banna, Giuseppe L., et al.
Publicado: (2017)

Lactobacillus rhamnosus GG Evaluation in Acute Diarrhea (LEAD): An Observational Study
por: Sanklecha, Mukesh, et al.
Publicado: (2022)

Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.
por: Huang, J. Q., et al.
Publicado: (1998)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015)

Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial
por: Khan, Mohammed Q.
Publicado: (2008)

High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis
por: Yang, Xue, et al.
Publicado: (2019)

A Randomized Clinical Trial Comparing Triple Therapy versus Non-bismuth based Quadruple Therapy for the Eradication of Helicobacter Pylori in Kuwait
por: Alfadhli, Ahmad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_05sts8lc4mgg0o4fip3jlk19fe